Universitätsklinikum Jena, Sektion Translationale Neuroimmunologie, Klinik für Neurologie
Welcome,         Profile    Billing    Logout  
 4 Trials 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Meuth, Sven
Generate-Boost, NCT03993262: Trial to Evaluate Efficacy and Safety of Bortezomib in Patients with Severe Autoimmune Encephalitis

Recruiting
2
50
Europe
Bortezomib, Placebo, isotonic NaCl solution
Jena University Hospital, Federal Ministry of Education and Reserach (BMBF)
Autoimmune Encephalitis
11/25
04/26
NCT05798520: A Study to Learn About the Safety of BIIB091 and Its Effect on Brain Inflammation When Taken Alone or With Diroximel Fumarate (DRF) in Adults With Relapsing Forms of Multiple Sclerosis (MS)

Recruiting
2
275
Europe, US, RoW
BIIB091, DRF, Placebo
Biogen
Relapsing Forms of Multiple Sclerosis
07/25
11/26
CIRMS, NCT05019248: Immune Response to Seasonal Influenza Vaccination in Multiple Sclerosis Patients Receiving Cladribine

Recruiting
N/A
260
Europe
Most recent vaccine to seasonal influenza
Heinrich-Heine University, Duesseldorf
Multiple Sclerosis, Relapsing-Remitting, Vaccine Response Impaired
12/21
04/22
Geis, Christian
NIMBLE, NCT05070858 / 2020-003272-41: A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis

Recruiting
3
235
Europe, Canada, Japan, US, RoW
Pozelimab + Cemdisiran, Cemdisiran, ALN-CC5, Placebo, Pozelimab, REGN3918
Regeneron Pharmaceuticals
Generalized Myasthenia Gravis
05/25
03/28
Generate-Boost, NCT03993262: Trial to Evaluate Efficacy and Safety of Bortezomib in Patients with Severe Autoimmune Encephalitis

Recruiting
2
50
Europe
Bortezomib, Placebo, isotonic NaCl solution
Jena University Hospital, Federal Ministry of Education and Reserach (BMBF)
Autoimmune Encephalitis
11/25
04/26

Download Options